176 related articles for article (PubMed ID: 28043861)
1. The importance of the hypothalamo-pituitary-adrenal axis as a therapeutic target in anorexia nervosa.
Bou Khalil R; Souaiby L; Farès N
Physiol Behav; 2017 Mar; 171():13-20. PubMed ID: 28043861
[TBL] [Abstract][Full Text] [Related]
2. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
Mattsson C; Reynolds RM; Simonyte K; Olsson T; Walker BR
J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
Breivik T; Gundersen Y; Gjermo P; Opstad PK
J Periodontal Res; 2014 Feb; 49(1):36-44. PubMed ID: 23586673
[TBL] [Abstract][Full Text] [Related]
4. Mifepristone as a therapeutic agent in psychiatry.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):11-4. PubMed ID: 23814820
[TBL] [Abstract][Full Text] [Related]
5. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress.
Wulsin AC; Herman JP; Solomon MB
Psychoneuroendocrinology; 2010 Aug; 35(7):1100-12. PubMed ID: 20149549
[TBL] [Abstract][Full Text] [Related]
7. Antiglucocoticoid treatments for depression.
Young AH
Aust N Z J Psychiatry; 2006 May; 40(5):402-5. PubMed ID: 16683965
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone reduces hypothalamo-pituitary-adrenal axis activation and restores weight loss in rats subjected to dietary restriction and methylphenidate administration.
Bou Khalil R; Smayra V; Saliba Y; Hajal J; Bakhos JJ; Souaiby L; Richa S; Tamraz J; Farès N
Neurosci Res; 2018 Oct; 135():46-53. PubMed ID: 29288690
[TBL] [Abstract][Full Text] [Related]
9. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
[TBL] [Abstract][Full Text] [Related]
10. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
Gross C; Blasey CM; Roe RL; Belanoff JK
Obesity (Silver Spring); 2010 Dec; 18(12):2295-300. PubMed ID: 20339369
[TBL] [Abstract][Full Text] [Related]
12. Activity of the hypothalamic-pituitary-adrenal axis is elevated in rats with activity-based anorexia.
Burden VR; White BD; Dean RG; Martin RJ
J Nutr; 1993 Jul; 123(7):1217-25. PubMed ID: 8320563
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression.
Watson S; Gallagher P; Porter RJ; Smith MS; Herron LJ; Bulmer S; ; Young AH; Ferrier IN
Biol Psychiatry; 2012 Dec; 72(11):943-9. PubMed ID: 22770649
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of Cushing's syndrome: an update.
Dang CN; Trainer P
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
[TBL] [Abstract][Full Text] [Related]
15. Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa.
Gordon CM; Emans SJ; DuRant RH; Mantzoros C; Grace E; Harper GP; Majzoub JA
Eat Weight Disord; 2000 Sep; 5(3):175-82. PubMed ID: 11082797
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol.
Xiao E; Xia L; Shanen D; Khabele D; Ferin M
Endocrinology; 1994 Nov; 135(5):2093-8. PubMed ID: 7956932
[TBL] [Abstract][Full Text] [Related]
17. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
Liu JP; Clarke IJ; Funder JW; Engler D
J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
[TBL] [Abstract][Full Text] [Related]
18. The Hypothalamic-Pituitary-Adrenal Axis and Anesthetics: A Review.
Besnier E; Clavier T; Compere V
Anesth Analg; 2017 Apr; 124(4):1181-1189. PubMed ID: 27984246
[TBL] [Abstract][Full Text] [Related]
19. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis.
Lombardo G; Enache D; Gianotti L; Schatzberg AF; Young AH; Pariante CM; Mondelli V
Psychoneuroendocrinology; 2019 Dec; 110():104420. PubMed ID: 31499391
[TBL] [Abstract][Full Text] [Related]
20. Cardiac arrest and resuscitation activates the hypothalamic-pituitary-adrenal axis and results in severe immunosuppression.
Zhao Q; Shen Y; Li R; Wu J; Lyu J; Jiang M; Lu L; Zhu M; Wang W; Wang Z; Liu Q; Hoffmann U; Karhausen J; Sheng H; Zhang W; Yang W
J Cereb Blood Flow Metab; 2021 May; 41(5):1091-1102. PubMed ID: 32787543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
